Comparison of content of FDA letters not approving applications for new drugs and associated public announcements from sponsors: cross sectional study. (Record no. 24971132)

MARC details
000 -LEADER
fixed length control field 01318 a2200361 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517034946.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201508s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1756-1833
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1136/bmj.h2758
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Lurie, Peter
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20150818
245 00 - TITLE STATEMENT
Title Comparison of content of FDA letters not approving applications for new drugs and associated public announcements from sponsors: cross sectional study.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. BMJ (Clinical research ed.)
Date of publication, distribution, etc. Jun 2015
300 ## - PHYSICAL DESCRIPTION
Extent h2758 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Consumer Product Safety
General subdivision legislation & jurisprudence
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Correspondence as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cross-Sectional Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Approval
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Industry
General subdivision legislation & jurisprudence
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Research Report
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element United States
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element United States Food and Drug Administration
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chahal, Harinder S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sigelman, Daniel W
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Stacy, Sylvie
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sclar, Joshua
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ddamulira, Barbara
773 0# - HOST ITEM ENTRY
Title BMJ (Clinical research ed.)
Related parts vol. 350
-- p. h2758
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1136/bmj.h2758">https://doi.org/10.1136/bmj.h2758</a>
Public note Available from publisher's website

No items available.